UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 377

Sortiert nach

Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomised phase 2 trial

The Lancet (British edition), 2016-07, Vol.388 (10043), p.488-497

2016

Link zum Volltext

Verfügbarkeit prüfen

SIRT3 deficiency decreases oxidative metabolism capacity but increases lifespan in male mice under caloric restriction

Aging cell, 2022-12, Vol.21 (12), p.e13721-n/a

2022

Link zum Volltext

Verfügbarkeit prüfen

Metabolomic Analysis of Carbohydrate and Amino Acid Changes Induced by Hypoxia in Naked Mole-Rat Brain and Liver

Metabolites, 2022-01, Vol.12 (1), p.56

2022

Link zum Volltext

Verfügbarkeit prüfen

A phase II trial of [fam-] trastuzumab deruxtecan (T-DXd, DS-8201a) in subjects with HER2-positive, unresectable, or metastatic gastric or gastroesophageal junction (GEJ) adenocarcinoma

Journal of clinical oncology, 2020-02, Vol.38 (4_suppl), p.TPS460-TPS460

2020

Link zum Volltext

Verfügbarkeit prüfen

A phase I study of olaratumab, an anti-platelet-derived growth factor receptor alpha (PDGFRα) monoclonal antibody, in patients with advanced solid tumors

Cancer chemotherapy and pharmacology, 2014-03, Vol.73 (3), p.595-604

2014

Link zum Volltext

Verfügbarkeit prüfen

Aging- and alcohol-associated spatial transcriptomic signature in mouse acute pancreatitis reveals heterogeneity of inflammation and potential pathogenic factors

Journal of molecular medicine (Berlin, Germany), 2024-08, Vol.102 (8), p.1051-1061

2024

Link zum Volltext

Verfügbarkeit prüfen

Abstract CT167: Pooled analysis of drug-related interstitial lung disease (ILD) in 8 single-arm trastuzumab deruxtecan (T-DXd) studies

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.CT167-CT167

2021

Link zum Volltext

Verfügbarkeit prüfen

Phase 1 study of the anti-vascular endothelial growth factor receptor 3 monoclonal antibody LY3022856/IMC-3C5 in patients with advanced and refractory solid tumors and advanced colorectal cancer

Cancer chemotherapy and pharmacology, 2016-10, Vol.78 (4), p.815-824

2016

Link zum Volltext

Verfügbarkeit prüfen

Biological Aging, Mortality, and Alzheimer’s Disease Related Biomarkers from Midlife to Old Age

Innovation in aging, 2021-12, Vol.5 (Supplement_1), p.662-663

2021

Link zum Volltext

Verfügbarkeit prüfen

Randomised phase II study of second-line olaratumab with mitoxantrone/prednisone versus mitoxantrone/prednisone alone in metastatic castration-resistant prostate cancer

European journal of cancer (1990), 2019-01, Vol.107, p.186-195

2019

Link zum Volltext

Verfügbarkeit prüfen

Phase II study of olaratumab with paclitaxel/carboplatin (P/C) or P/C alone in previously untreated advanced NSCLC

Lung cancer (Amsterdam, Netherlands), 2017-09, Vol.111, p.108-115

2017

Link zum Volltext

Verfügbarkeit prüfen

Phase I study of anti-VEGF receptor-3 (VEGFR-3) monoclonal antibody (mab) LY3022856/IMC-3C5 (3C5)

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.3530-3530

2015

Link zum Volltext

Verfügbarkeit prüfen

Associations of smoking and biohazard exposure with Alzheimer’s disease brain and plasma biomarkers in early old age

Alzheimer's & dementia, 2021-12, Vol.17 (S10), p.n/a

2021

Link zum Volltext

Verfügbarkeit prüfen

A randomized phase 2 study of a human antiplatelet-derived growth factor α (PDGFRα) monoclonal antibody (olaratumab, IMC-3G3) with paclitaxel/carboplatin or paclitaxel/carboplatin alone in previously untreated patients with advanced non-small cell lung cancer (NSCLC)

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.8050-8050

2014

Link zum Volltext

Verfügbarkeit prüfen

Olaratumab and doxorubicin versus doxorubicin alone in soft tissue sarcoma

The Lancet (British edition), 2016-06, Vol.388 (10043), p.488-497

2016

Link zum Volltext

Verfügbarkeit prüfen

APOE‐e4 Status Moderates Associations between Executive Function and Air Pollution Exposure in Older Men

Alzheimer's & dementia, 2022-12, Vol.18 (S11), p.n/a

2022

Link zum Volltext

Verfügbarkeit prüfen

A randomized phase Ib/II study evaluating the safety and efficacy of olaratumab (IMC-3G3), a human anti-platelet-derived growth factor α (PDGFRα) monoclonal antibody, with or without doxorubicin (Dox), in advanced soft tissue sarcoma (STS)

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.10501-10501

2015

Link zum Volltext

Verfügbarkeit prüfen

Crosstalk Between Metabolism and Epigenetics: From the Acetyltransferase P300 to the Deacetylase SIRT3

Qin, Yiming (Amy)

2022

Link zum Volltext

Verfügbarkeit prüfen

ALVEOLAR MACROPHAGE CYTOKINE PRODUCTION IN RESPONSE TO AIR PARTICLES IN VITRO: ROLE OF ENDOTOXIN

Journal of Toxicology and Environmental Health, Part A, 2000-02, Vol.59 (3), p.165-180

Yaoyu Ning, Amy Imrich, Carroll-Ann Goldsmith, Guozhong Qin, Lester Kobzik

2000

Link zum Volltext

Verfügbarkeit prüfen

Identification of metastasis‐related microRNAs in hepatocellular carcinoma

Hepatology (Baltimore, Md.), 2008-03, Vol.47 (3), p.897-907

2008

Link zum Volltext

Verfügbarkeit prüfen

Patterned human microvascular grafts enable rapid vascularization and increase perfusion in infarcted rat hearts

Nature communications, 2019-02, Vol.10 (1), p.584-14, Article 584

2019

Link zum Volltext

Verfügbarkeit prüfen

Management of Stage III Non-Small-Cell Lung Cancer: ASCO Guideline

Journal of clinical oncology, 2022-04, Vol.40 (12), p.1356-1384

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 377

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(357)
Mit Volltextzugriff
(339)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(245)
Life Sciences & Biomedicine
(195)
Humans
(141)
Animals
(76)
Female
(62)
Male
(59)
Mice
(45)
Science & Technology - Other Topics
(32)
Middle Aged
(30)
Multidisciplinary Sciences
(29)
Biochemistry & Molecular Biology
(28)
Physical Sciences
(28)
Adult
(26)
Aged
(26)
Oncology
(26)
Biological And Medical Sciences
(24)
Immunology
(20)
Cell Biology
(19)
Infectious Diseases
(18)
Medical Sciences
(18)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomised phase 2 trial

SIRT3 deficiency decreases oxidative metabolism capacity but increases lifespan in male mice under caloric restriction

Metabolomic Analysis of Carbohydrate and Amino Acid Changes Induced by Hypoxia in Naked Mole-Rat Brain and Liver

A phase II trial of [fam-] trastuzumab deruxtecan (T-DXd, DS-8201a) in subjects with HER2-positive, unresectable, or metastatic gastric or gastroesophageal junction (GEJ) adenocarcinoma

Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses from a single-arm, phase 2 study

A phase I study of olaratumab, an anti-platelet-derived growth factor receptor alpha (PDGFRα) monoclonal antibody, in patients with advanced solid tumors

Aging- and alcohol-associated spatial transcriptomic signature in mouse acute pancreatitis reveals heterogeneity of inflammation and potential pathogenic factors

Abstract CT167: Pooled analysis of drug-related interstitial lung disease (ILD) in 8 single-arm trastuzumab deruxtecan (T-DXd) studies

Phase 1 study of the anti-vascular endothelial growth factor receptor 3 monoclonal antibody LY3022856/IMC-3C5 in patients with advanced and refractory solid tumors and advanced colorectal cancer

Biological Aging, Mortality, and Alzheimer’s Disease Related Biomarkers from Midlife to Old Age

Randomised phase II study of second-line olaratumab with mitoxantrone/prednisone versus mitoxantrone/prednisone alone in metastatic castration-resistant prostate cancer

Phase II study of olaratumab with paclitaxel/carboplatin (P/C) or P/C alone in previously untreated advanced NSCLC

Phase I study of anti-VEGF receptor-3 (VEGFR-3) monoclonal antibody (mab) LY3022856/IMC-3C5 (3C5)

Associations of smoking and biohazard exposure with Alzheimer’s disease brain and plasma biomarkers in early old age

A randomized phase 2 study of a human antiplatelet-derived growth factor α (PDGFRα) monoclonal antibody (olaratumab, IMC-3G3) with paclitaxel/carboplatin or paclitaxel/carboplatin alone in previously untreated patients with advanced non-small cell lung cancer (NSCLC)

Olaratumab and doxorubicin versus doxorubicin alone in soft tissue sarcoma

APOE‐e4 Status Moderates Associations between Executive Function and Air Pollution Exposure in Older Men

A randomized phase Ib/II study evaluating the safety and efficacy of olaratumab (IMC-3G3), a human anti-platelet-derived growth factor α (PDGFRα) monoclonal antibody, with or without doxorubicin (Dox), in advanced soft tissue sarcoma (STS)

Crosstalk Between Metabolism and Epigenetics: From the Acetyltransferase P300 to the Deacetylase SIRT3

ALVEOLAR MACROPHAGE CYTOKINE PRODUCTION IN RESPONSE TO AIR PARTICLES IN VITRO: ROLE OF ENDOTOXIN

Identification of metastasis‐related microRNAs in hepatocellular carcinoma

Patterned human microvascular grafts enable rapid vascularization and increase perfusion in infarcted rat hearts

Management of Stage III Non-Small-Cell Lung Cancer: ASCO Guideline

Sensory Neurons Co-opt Classical Immune Signaling Pathways to Mediate Chronic Itch

Efficacy and safety of oral immunotherapy in children aged 1–3 years with peanut allergy (the Immune Tolerance Network IMPACT trial): a randomised placebo-controlled study

Suchergebnisse filtern